Jason Pitofsky Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Jason Pitofsky is VP Controller of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 5,308 shares of REGN, which is worth approximately $3.68 Million. The most recent transaction as insider was on Dec 08, 2025, when has been sold 989 shares (Common Stock) at a price of $712.94 per share, resulting in proceeds of $705,097. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.31K

13.81% 3M change

13.81% 12M change

Total Value Held $3.68 Million

Jason Pitofsky Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 08 2025	SELL Payment of exercise price or tax liability	$705,097 $712.94 p/Share	989 Reduced 15.71%	5,308 Common Stock
Dec 05 2025	BUY Grant, award, or other acquisition	-	2,064 Added 24.69%	6,297 Common Stock
Nov 07 2025	SELL Open market or private sale	$280,766 $651.43 p/Share	431 Reduced 9.24%	4,233 Common Stock
Dec 16 2024	SELL Payment of exercise price or tax liability	$217,781 $730.81 p/Share	298 Reduced 6.01%	4,664 Common Stock
Dec 09 2024	SELL Payment of exercise price or tax liability	$117,263 $787.0 p/Share	149 Reduced 2.92%	4,962 Common Stock
Dec 06 2024	BUY Grant, award, or other acquisition	-	907 Added 15.07%	5,111 Common Stock
Aug 07 2024	SELL Open market or private sale	$521,090 $1070.0 p/Share	487 Reduced 10.38%	4,204 Common Stock

Aug 07 2024	BUY Exercise of conversion of derivative security	$181,388 $372.46 p/Share	487 Added 9.41%	4,691 Common Stock

Jason Pitofsky

VP Controller

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account